PGIM Jennison Health Sciences Fund - Class Z (PHSZX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
42.10
-0.36 (-0.85%)
Jul 28, 2025, 4:00 PM EDT
-0.85%
Fund Assets1.36B
Expense Ratio0.86%
Min. Investment$0.00
Turnover79.00%
Dividend (ttm)5.40
Dividend Yield13.03%
Dividend Growth182.36%
Payout FrequencyAnnual
Ex-Dividend DateDec 20, 2024
Previous Close42.46
YTD Return-3.26%
1-Year Return-2.17%
5-Year Return50.96%
52-Week Low37.90
52-Week High54.68
Beta (5Y)n/a
Holdings45
Inception DateJun 30, 1999

About PHSZX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on long-term capital appreciation by investing primarily in the healthcare sector. It targets companies involved in drugs, healthcare services, and biotechnology, aiming to capitalize on the growth potential of these industries. The fund's portfolio is composed of a mix of large-cap healthcare companies, with a significant portion of its assets allocated to top holdings in this sector. Its high-conviction strategy is managed by experienced healthcare specialists, appealing to investors seeking dedicated exposure to the healthcare market. The fund's role in the financial market is to provide a concentrated investment opportunity for those interested in the healthcare industry's potential for growth and innovation.

Fund Family PGIM Investments
Category Health
Stock Exchange NASDAQ
Ticker Symbol PHSZX
Share Class Class Z
Index S&P Composite 1500 Health Care TR

Performance

PHSZX had a total return of -2.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.96%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHLAXClass A1.13%
PJHRXClass R1.48%
PHLCXClass C1.96%

Top 10 Holdings

57.84% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY14.60%
Prudential Govt Money Mkt Fdn/a10.96%
Vertex Pharmaceuticals IncorporatedVRTX4.95%
argenx SEARGX4.85%
Neurocrine Biosciences, Inc.NBIX4.78%
AstraZeneca PLCAZN4.64%
Thermo Fisher Scientific Inc.TMO3.58%
Novo Nordisk A/SNVO3.50%
Alnylam Pharmaceuticals, Inc.ALNY3.15%
UnitedHealth Group IncorporatedUNH2.85%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 20, 2024$5.40216Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Dec 20, 2018$4.77761Dec 20, 2018
Full Dividend History